Literature DB >> 17993925

A lifestyle-based weight management program delivered to employees: examination of health and economic outcomes.

M Courtney Hughes1, Teresa M Girolami, Allen D Cheadle, Jeffrey R Harris, Donald L Patrick.   

Abstract

OBJECTIVE: To examine the health and economic outcomes associated with a comprehensive weight management program delivered to employees.
METHODS: Data collected on 516 individuals participating in a lifestyle-based weight management program delivered to employees from three corporations were analyzed at baseline and intervention-end (26 or 52 weeks). One-year post-intervention data for two subgroups were examined for pharmaceutical use (n = 61) and health outcomes (n = 46).
RESULTS: Average body weight decreased 5.4% (P < 0.001) and average waist circumference decreased 7.2% (P < 0.001). Average blood pressure, Beck Depression Inventory scores, and Rosenberg Self-Esteem Scale scores improved (P < 0.001). At 1-year post-intervention, weight loss was maintained in a subgroup of 46 individuals. The average number of prescription drugs taken per participant decreased 44% in a subgroup of 61 individuals.
CONCLUSIONS: An employer-sponsored, comprehensive weight management program may decrease weight, improve obesity-related outcomes, improve depressive symptoms, and decrease costs.

Entities:  

Mesh:

Year:  2007        PMID: 17993925     DOI: 10.1097/JOM.0b013e318159489d

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

Review 1.  Strategies for Worksite Health Interventions to Employees with Elevated Risk of Chronic Diseases.

Authors:  Lu Meng; Marilyn B Wolff; Kelly A Mattick; David M DeJoy; Mark G Wilson; Matthew Lee Smith
Journal:  Saf Health Work       Date:  2016-12-02

2.  Treadmill workstations: the effects of walking while working on physical activity and work performance.

Authors:  Avner Ben-Ner; Darla J Hamann; Gabriel Koepp; Chimnay U Manohar; James Levine
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.